Search - tctmd.com

Displaying 261 - 280 of 295

Sort: Relevancy | Date

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Daily News

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Caitlin E. Cox

August 05, 2011

News Daily News

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

L.A. McKeown

August 05, 2011

News Daily News

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Caitlin E. Cox

August 03, 2011

News Daily News

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

L.A. McKeown

August 02, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Daily News

DES Show Advantage over BMS for Heart Transplant Complication

L.A. McKeown

July 01, 2011

News Industry News

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

June 26, 2011

News Daily News

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

L.A. McKeown

June 15, 2011

News Industry News

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

June 15, 2011

News Daily News

EES Show Long-term Safety Advantage over SES

L.A. McKeown

May 24, 2011

News Conference News

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Caitlin E. Cox

May 20, 2011

News Conference News

Long-Term Imaging Study Evaluates Vascular Healing in First-Gen DES

Jason Kahn

May 19, 2011

News Industry News

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

May 19, 2011

News Daily News

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Leah Lawrence

April 26, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Caitlin E. Cox

April 05, 2011

Advertisement

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

DES Show Advantage over BMS for Heart Transplant Complication

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

EES Show Long-term Safety Advantage over SES

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Long-Term Imaging Study Evaluates Vascular Healing in First-Gen DES

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Therapies Take on In-Stent Restenosis with Mixed Results

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content